ralometostat
Generic: Ralometostat
ralometostat: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Tango Therapeutics, Inc. (TNGX) | Phase 1/Phase 2 |
Clinical Trials (1)
A Phase 1/2, Multi-Center, Open-Label Study to Evaluate the Safety, Tolerability, and Preliminary Anti-tumor Activity of TNG908 in Patients With MTAP-deleted Advanced or Metastatic Solid Tumors
Frequently asked questions
Who is developing ralometostat?
ralometostat is being developed by Tango Therapeutics, Inc..
How many clinical trials involve ralometostat?
BioSniper tracks 1 clinical trial involving ralometostat.
Get deeper analysis on ralometostat
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis